{
    "clinical_study": {
        "@rank": "50113", 
        "biospec_descr": {
            "textblock": "5 mL of cerebrospinal fluid (CSF) will be collected in this study at one time point."
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "The purpose of this study is to obtain cerebrospinal fluid from healthy children already\n      undergoing a lumbar puncture procedure at New York Presbyterian Hospital, to act as healthy\n      controls when compared to children with late infantile neuronal ceroid lipofuscinosis\n      (LINCL), a fatal neurodegenerative disease."
        }, 
        "brief_title": "Collection of Cerebrospinal Fluid in Healthy Children", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Late Infantile Neuronal Ceroid Lipofuscinosis", 
            "Batten Disease"
        ], 
        "condition_browse": {
            "mesh_term": "Neuronal Ceroid-Lipofuscinoses"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Males and females, ages 2 yrs to 8 yrs\n\n          -  Children already undergoing a lumbar puncture procedure for clinical or diagnostic\n             purposes\n\n        Exclusion Criteria:\n\n          -  Presence of any significant neurological diseases, as judged by the co-investigators\n\n          -  Presence of any significant medical conditions including cancer"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "8 Years", 
            "minimum_age": "2 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Subjects will be healthy controls (children ages 2 years to 8 years) undergoing a lumbar\n        puncture at New York Presbyterian Hospital, for clinical care purposes. They will be\n        inpatients and outpatients."
            }
        }, 
        "enrollment": {
            "#text": "32", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 15, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01698229", 
            "org_study_id": "1111012024"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Cerebrospinal fluid", 
            "Lumbar puncture", 
            "Spinal tap", 
            "Late infantile neuronal ceroid lipofuscinosis", 
            "Batten disease"
        ], 
        "lastchanged_date": "September 27, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "New York", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "10065"
                }, 
                "name": "Weill Cornell Medical College / New York Presbyterian Hospital"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Collection of Cerebrospinal Fluid in Healthy Children", 
        "overall_official": {
            "affiliation": "Weill Medical College of Cornell University", 
            "last_name": "Ronald G Crystal, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": [
                "United States: Institutional Review Board", 
                "United States: Clinical and Translational Science Center"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_outcome": {
            "description": "The primary study endpoint is the metabolic profiling of 32 samples of cerebrospinal fluid from healthy subjects, in comparison to 32 samples of CSF from children with LINCL, to determine whether there are biomarkers found in the cerebrospinal fluid that are associated with LINCL.", 
            "measure": "Cerebrospinal fluid (CSF)", 
            "safety_issue": "No", 
            "time_frame": "1 time point (once)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01698229"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Weill Medical College of Cornell University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Weill Medical College of Cornell University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2011", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "September 2012"
    }
}